APA (7th ed.) Citation

LL, W., K, S., A, C., JW, F., & CJ, S. (2025). Safety and efficacy of biologics in patients with Down syndrome and hidradenitis suppurativa: A retrospective cohort study. Clinical and experimental dermatology, 50(7), 1431. https://doi.org/10.1093/ced/llaf090

Chicago Style (17th ed.) Citation

LL, Westerkam, Santiago-Soltero K, Charrow A, Frew JW, and Sayed CJ. "Safety and Efficacy of Biologics in Patients with Down Syndrome and Hidradenitis Suppurativa: A Retrospective Cohort Study." Clinical and Experimental Dermatology 50, no. 7 (2025): 1431. https://doi.org/10.1093/ced/llaf090.

MLA (9th ed.) Citation

LL, Westerkam, et al. "Safety and Efficacy of Biologics in Patients with Down Syndrome and Hidradenitis Suppurativa: A Retrospective Cohort Study." Clinical and Experimental Dermatology, vol. 50, no. 7, 2025, p. 1431, https://doi.org/10.1093/ced/llaf090.